Author

G. Alfama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. Fontaine· 2 shared C. de Lombares· 2 shared G. Levi· 2 shared N. Narboux-Neme· 2 shared A. Bachelot· 1 shared B. Bellessort· 1 shared C. Pirazzini· 1 shared C. Vernochet· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

A. Fontaine

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dlx5 and Dlx6 expression in GABAergic neurons controls behavior, metabolism, healthy aging and lifespan.

C. de Lombares, E. Heude, G. Alfama, A. Fontaine, R. Hassouna, C. Vernochet, F. de Chaumont, J.-C. Olivo-Marin, E. Ey, S. Parnaudeau, F. Tronche, T. Bourgeron, S. Luquet, G. Levi, N. Narboux-Neme

This study shows that Dlx5 and Dlx6 in GABAergic neurons affect behavior, metabolism, aging, and lifespan in mice.

bioRxiv · Mar 20, 2019Physiology

Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain

B. Bellessort, A. Bachelot, V. Grouthier, C. De Lombares, N. Narboux-Neme, P. Garagnani, C. Pirazzini, S. Astigiano, L. Mastracci, A. Fontaine, G. Alfama, E. Duvernois-Berthet, G. Levi

The paper identifies CACNA2D1, CACNA2D2, and CACNA2D3 as potential targets for gabapentin in treating endometriosis-associated pain through comparative gene expression analysis.

bioRxiv · Jan 22, 2018Pharmacology & Toxicology